Trial Profile
Replacement therapy with modified-release hydrocortisone (Plenadren) in patients with central adrenal insufficiency
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2014
Price :
$35
*
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Adrenal insufficiency
- Focus Therapeutic Use
- 29 Jul 2014 New trial record